Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
CytomX Therapeutics Inc banner

CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 3.285 USD -1.94% Market Closed
Market Cap: $715.1m
Write Note Create Alert Ask AI

Wall St Price Targets

CTMX Price Targets Summary
CytomX Therapeutics Inc

Wall Street analysts forecast CTMX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTMX is 12.677 USD with a low forecast of 6.06 USD and a high forecast of 16.8 USD.

CTMX Lowest Forecast
Wall Street Target
$6.06
84% Upside
CTMX Average Forecast
Wall Street Target
$12.677
286% Upside
CTMX Highest Forecast
Wall Street Target
$16.8
411% Upside
Lowest Forecast
Price Target
6.06 USD
84% Upside
Average Forecast
Price Target
12.677 USD
286% Upside
Highest Forecast
Price Target
16.8 USD
411% Upside
CytomX Therapeutics Inc Competitors:
Price Targets
UFPT
UFP Technologies Inc
31% Upside
TCPC
BlackRock TCP Capital Corp
10% Upside
T
TRIN
Trinity Capital Inc
5% Upside
CENT
Central Garden & Pet Co
32% Upside
UFPT
UFP Technologies Inc
31% Upside
TCPC
BlackRock TCP Capital Corp
10% Upside
T
TRIN
Trinity Capital Inc
5% Upside
CENT
Central Garden & Pet Co
32% Upside
ENVX
Enovix Corp
269% Upside
NN
NextNav Inc
132% Upside
QNST
Quinstreet Inc
27% Upside
AMAL
Amalgamated Bank
14% Upside

Revenue
Forecast

28% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
28% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 28%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

What are analyst estimates?

Continue CTMX Research

Summary
CTMX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CTMX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CTMX stock valuation using valuation multiples.
Wall St Estimates
CTMX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CTMX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other CytomX Therapeutics Inc listings:
F • EUR
6C1
 SWB • EUR
6C1
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CTMX's stock price target?
Price Target
12.677 USD

According to Wall Street analysts, the average 1-year price target for CTMX is 12.677 USD with a low forecast of 6.06 USD and a high forecast of 16.8 USD.

What is the Revenue forecast for CytomX Therapeutics Inc?
Projected CAGR
28%

Over the last 11 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett